This speculation follows from studies showing that inhibition of the PTEN/mTOR pathway provides protection against many pathologies including neurodegenerative diseases, cancer, heart diseases, obesity and kidney disease [41]–[43]. Here, PTEN is linked to obesity due to melanocortin 4 receptor deficiency.